---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-002763"
form_type: "8-K"
ticker: "SENS"
cik: "0001616543"
company_name: "Senseonics Holdings, Inc."
filed_at: "2023-01-10T23:59:59+00:00"
generated_at: "2026-06-20T17:07:12.093745+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Senseonics adopts 2023 Commercial Equity Plan for partner Ascensia employees; up to 10M shares

## Summary
- Board adopted 2023 Commercial Equity Plan on Jan 10, 2023 to grant stock options and RSUs to employees of commercial partner Ascensia Diabetes Care.
- Plan reserves 10,000,000 shares of common stock for issuance, subject to performance-based vesting.
- Grants require SEC Form S-3 registration statement to be declared effective before awards can be issued.
- Plan aims to align incentives of individuals supporting Eversense commercialization with shareholder interests.
- Eligible recipients include Ascensia employees assisting with commercialization, who are ineligible for the existing 2015 Equity Incentive Plan.

## SEC filing metadata
- accession: 0001104659-23-002763
- form_type: 8-K
- ticker: SENS
- cik: 0001616543
- company_name: Senseonics Holdings, Inc.
- filed_at: 2023-01-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1616543/000110465923002763/0001104659-23-002763-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1616543/000110465923002763/tm232916d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-002763
- JSON: https://secwatch.observer/filing/0001104659-23-002763.json
- Plain text: https://secwatch.observer/filing/0001104659-23-002763.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.